Novartis AG (SWX:NOVN) is looking for bolt-on acquisitions. Vasant Narasimhan, CEO said, "I think we can say is that we know that given the strong cash flow that we generate at Novartis, we have the ability to continue to do bolt-on acquisitions, like we've done in the past, when we find attractive assets that fit with our therapeutic area goals and our platform goals".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.49 CHF | +0.45% | +4.13% | +10.16% |
05-13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
05-10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.16% | 209B | |
+29.90% | 682B | |
+30.35% | 586B | |
-3.68% | 364B | |
+17.67% | 327B | |
+3.27% | 285B | |
+15.53% | 240B | |
-8.14% | 203B | |
+7.59% | 165B | |
-1.98% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Seeks Bolt-On Acquisitions